Originally published In Press as doi:10.1074/jbc.M201245200 on March 26, 2002
J. Biol. Chem., Vol. 277, Issue 22, 19339-19345, May 31, 2002
Formation of Disulfide Bridges by a Single-chain Fv Antibody in
the Reducing Ectopic Environment of the Plant Cytosol*
Alexander
Schouten
,
Jan
Roosien,
Jaap
Bakker, and
Arjen
Schots
From the Laboratory of Nematology/Laboratory of Molecular
Recognition and Antibody Technology, Department of Plant Sciences,
Wageningen University, P. O. Box 8123, 6700 ES Wageningen, The Netherlands
Received for publication, February 6, 2002, and in revised form, March 19, 2002
 |
ABSTRACT |
Disulfide bridge formation in the reducing
environment of the cytosol is considered a rare event and is mostly
linked to inactivation of protein activity. In this report the in
vivo redox state of a single-chain Fv (scFv) antibody fragment in
the plant cytosol was investigated. The scFv antibody fragment consists
of the variable light and heavy chain domains from a mouse IgG
antibody, which are connected by a flexible linker peptide. In each
domain one disulfide bridge is present. The functionality of
antibodies, which are normally secreted via the oxidizing environment
of the endoplasmic reticulum, depends on the formation of
intramolecular disulfide bridges. We demonstrate that a scFv can form
intramolecular disulfide bridges and is functionally expressed in the
cytosol of stably transformed plants. In addition, the formation of
intermolecular disulfide bridges through a cysteine present in the
linker peptide was observed. In contrast, transient expression in
tobacco protoplasts resulted in a cytosolic scFv lacking disulfide
bridges, which had a substantially reduced affinity for the antigen.
This indicates that functionality rather than stability is determined
by the presence of disulfide bridges in the in
planta-expressed scFv antibody. The controversial observation of
disulfide bond formation in the cytosol is discussed.
 |
INTRODUCTION |
Disulfide bond formation and disulfide rearrangements are
reversible processes and are kinetically and thermodynamically affected by the redox state of the environment (1-3). In eukaryotic cells, subcellular compartmentation plays an important role in the regulation of these reversible thiol-disulfide exchange reactions. Glutathione is
the most abundant non-protein thiol in eukaryotic cells, and the
preferential transport of the disulfide form (GSSG) compared with the
reduced form (GSH) into the ER1 lumen is thought to be
responsible in maintaining redox compartmentation between the
ER and cytosol. For murine hybridoma
cells, it was shown that in the secretory pathway the ratio of reduced
glutathione to the disulfide form (GSH/GSSG) ranged from 1 to 3, whereas the overall cellular GSH/GSSG ratio ranged from 30 to 100 (3). In vitro studies show that the redox environment of the ER
corresponds with the optimum for refolding of disulfide-bonded proteins
(3). In the ER, disulfide formation and rearrangements are further enhanced by protein disulfide isomerase (4).
As soon as the N-terminal part of a nascent polypeptide chain enters
the oxidizing environment of the ER, folding starts with the aid of a
full array of molecular chaperones and folding catalysts. Failure of
disulfide formation has an adverse effect on various processes ranging
from protein folding, oligomerization, and intracellular transport to
secretion (5-10). In extracellular proteins containing cysteine
residues, there is rarely more than one free thiol group (11). Free
thiols are considered extremely reactive in the oxidizing extracellular
environment and may lead to disastrous polymerization or make folding
more complex (11). The extracellular protein albumin carries a reactive
free cysteine, but when not buried in the tertiary structure, this
residue performs a specific physiological function (12, 13).
The general idea is that the typical glutathione redox state of the
cytosol in eukaryotic cells does not favor the formation of protein
disulfide bonds (2, 11). Also in prokaryotic organisms, intracellular
disulfide bond formation seems to be hindered by the redox potential.
Many recombinant proteins with disulfide bonds cannot fold properly in
Escherichia coli, where the intracellular GSH-GSSG ratio
ranges from 50 to 200 (3). On the other hand, it has been suggested
that the redox state of the cytosol in eukaryotes is not constant and
may change in response to e.g. physiological and metabolic
stimuli. Also specialized intracellular compartmentation may provide
localized environments within the cell where the thiol-disulfide redox
state may be very different from that of the bulk cytoplasm. However,
apart from the comparison of the redox state of the ER with the
intracellular environment as a whole, techniques to monitor changes or
subtle subcellular redox compartmentation are nonexistent. Nevertheless, various lines of evidence indicate that redox modulation for some specific cytosolic proteins is an important regulatory mechanism in eukaryotic organisms (14, 15). In vitro studies demonstrate that various cytosolic enzymes are reversibly activated or
inactivated upon incubation with disulfides or thiols (16, 17).
Disulfide bridges are often associated with an inactivated protein (1,
18). These observations are consistent with metabolic changes in cell
cultures, perfused organs, and whole animals induced by manipulating
the cellular thiol to disulfide balance by applying reducing agents (7,
19-21). Although the biological significance of reversible
thiol-disulfide exchange reactions for the cytosol remains
controversial, in chloroplasts there is little question about the role
of redox modulation in regulating the activity of key enzymes (2, 22).
Also, for nuclei, evidence has been obtained that redox modulation
influences the activity of transcription factors (2).
In this report the redox states of scFv antibodies located in either
the ER or the cytosol of tobacco (Nicotiana tabacum) were
compared. We establish that in transgenic plants intramolecular disulfide bridges are present in both the cytosolic scFv and the scFv
located in the ER. The cytosolic scFv has binding properties that are
similar to the scFv located in the ER. Furthermore, the scFvs present
in the cytosol are, like the scFvs in the ER, capable of forming
intermolecular disulfides through a cysteine present in the linker
peptide. Transient expression of the scFv in the ER of tobacco
protoplasts also shows intramolecular and intermolecular disulfide
bridges. Remarkably, no disulfide bridges are present when the scFv
gene is expressed transiently in the cytosol. Although the expression
levels are comparable with those in transgenic plants, the binding
properties of this cytosolic scFv are very poor. The relationships
between transformation system, subcellular location, redox potential,
and disulfide bridge formation of heterologous proteins in the plant
cytosol and the possible consequences are discussed.
 |
EXPERIMENTAL PROCEDURES |
Cell Lines, Strains, and Cloning Vectors--
A scFv directed
against a fungal cutinase was derived from mouse immunoglobulin
cDNA of the hybridoma cell line 21C5 (23). Cloning procedures were
according to Sambrook et al. (24) using the E. coli strains DH5
, TG1, and 190 and the scFv cloning vectors pNEM5 and pNEM5K (23). For construction of the various 21C5 anti-cutinase scFv genes, the pNEM-scFv-K (23) was used.
Transgenic tobacco plants expressing scFv-SK and scFv-CK (23,
25) were used for analysis. As a control we used untransformed tobacco
(N. tabacum cv. Samsun NN) or a transgenic tobacco plant that was transformed with the empty transformation vector pCPO33T (23).
For transient expression assays, tobacco leaf protoplasts were
transfected using pRAP-scFv-SK, pRAP-scFv-CK (25), and as a control,
the empty transient expression vector pUCAP35S (26) was used.
ScFv Modifications--
To replace the cysteine residue in the
linker of the anti-cutinase scFv 21C5 by a serine residue, the
XhoI/PvuII fragment in pNEM-scFv was replaced by
a suitable adapter (5'-TCGAGTCTGAGGTCCAG-3' and 5'-CTGGACCTCAGAC-3'),
resulting in the pNEM-scFvser (Fig.
1). The scFv constructs were cloned as
SalI/NotI fragments from pNEM-scFvser
into pRAP-scFv-SK, creating and pNEM-scFvser-SK. All
modifications were verified by sequencing (27).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Diagram of the scFv-SK,
scFvser-SK and scFv-CK constructs. In the
scFvser-SK construct the cysteine residue present in the
linker peptide was replaced by serine. The N-terminal signal peptide
(SP), the single chain antibody construct (scFv)
with the variable light (VL) and heavy
(VH) chain domains connected by the linker peptide
(L), the location of the two cysteines (boxed C)
in each variable domain, which can form intramolecular disulfide
bridges ( ), and the C-terminal c-Myc tag (t) followed by
the KDEL peptide sequence (K) are indicated.
|
|
Preparation of Protoplasts and Transient Gene Expression by
Transfection--
Protoplasts were obtained from transformed tobacco
plants expressing scFv antibodies in the ER and cytosol at a level of 1 and 0.2% of total soluble protein (23) by the method described (28).
As a control, protoplasts were isolated from untransformed tobacco
leaves (N. tabacum cv. Samsun NN).
For transient gene expression assays the same procedure was used to
obtain protoplasts from tobacco leaves (N. tabacum cv. Samsun NN). Then plasmid DNA was transfected to the protoplasts according to the polyethylene glycol procedure as described (28).
Analysis of Intrachain Disulfide Bonds--
The protoplasts from
stable transformants or from a transfection assay expressing both
scFv-SK and scFv-CK proteins were separated from the incubation medium
and lysed by adding an equal volume of 10 mM Tris-HCl, pH
8.0, 1 mM EDTA, 1 mM Pefabloc, 80 mM N-ethylmaleimide (NEM), and subsequent
vortexing. The suspension was kept at 0 °C for 5 min and at room
temperature for 10 min. The chloroplasts were removed from the lysate
by centrifugation, and the supernatant was split into two portions. The
first portion received one-third volume of 4× SDS-PAGE sample buffer
containing 244 mM Tris-HCl, pH 6.8, 8% (w/v) SDS, 50%
(w/v) glycerol, and the second portion received one-third volume of 4×
SDS-PAGE sample buffer and dithiothreitol (DTT) to a final
concentration of 55 mM. Both samples were boiled for 5 min.
To the DTT-containing portion NEM was added to a final concentration of
200 mM and incubated for 15 min at room temperature. The
proteins were pelleted by ethanol precipitation and subsequent centrifugation. After drying, the pellet was resuspended in 1× SDS-PAGE sample buffer with 0.008% (w/v) bromphenol blue. Protein samples were loaded on a 13% SDS-polyacrylamide gel (29) (Bio-Rad mini-protean system). After electrophoresis the proteins were transferred to a polyvinylidene difluoride membrane (Millipore) by
electroblotting. For immunodetection, the membranes were incubated with
1:1000-diluted anti-c-Myc monoclonal antibody (9E10) (30) followed by a
1:5000-diluted rat-anti-mouse alkaline phosphatase conjugate (Jackson
ImmunoResearch). The blots were stained in 0.1 M
ethanolamine-HCl, pH 9.6, supplemented with 4 mM
MgCl2, 5-bromo-4-chloro-3-indolyl phosphate (0.06 mg/ml)
and nitro blue tetrazolium (0.1 mg/ml). The relative molecular weights
of the proteins were estimated with pre-stained low range molecular
weight markers (Bio-Rad).
Analysis of Interchain Disulfide Bonds--
Protoplasts
transfected with scFv-SK and scFvser-SK were separated from
the incubation medium and lysed by adding an equal volume of 10 mM Tris-HCl, pH 8.0, 1 mM EDTA, and 1 mM Pefabloc SC (Roche Molecular Biochemicals) and
subsequent vortexing. The chloroplasts were removed from the lysate by
centrifugation at 13,000 × g for 2 min. For Western
analysis one-third volume 4× SDS-PAGE sample buffer was added to an
aliquot of the supernatant, equaling 3 × 104
protoplasts. DTT and bromphenol blue were added to final concentrations of 40 mM and 0.008% (w/v), respectively, and the samples
were boiled at 100 °C for 5 min. For non-reducing gel
electrophoresis, DTT was omitted during sample preparation. The protein
samples were analyzed by SDS-polyacrylamide gel followed by
electroblotting and immunodetection as described above.
Affinity of Oxidized and Reduced Anti-cutinase scFv for Its
Antigen--
The affinity of the oxidized and reduced scFv for
cutinase was determined by quantitative ELISA. To prevent disulfide
bridge formation during sample preparation, alkylated protein samples were prepared as followed. The proteins from transgenic plants were
extracted by grinding 0.2-0.4 g of tobacco leaves in liquid nitrogen
to a fine powder. The powder was transferred to an Eppendorf tube and
mixed 1:2 (w/v) with 10 mM Tris-HCl, pH 8.0, 5 mM EDTA, 60 mM NEM, 1 mM Pefabloc
SC (Roche Molecular Biochemicals) and subsequent vortexing. As a
control, extracts were prepared in the presence of 4% ethanol (the
solvent of NEM) instead of NEM. The suspension was kept at 0 °C for
5 min and at room temperature for 10 min. Insoluble material was
removed by centrifugation at 13.000 × g. To the
supernatant, 25% (v/v) 5× PBS, 0.5% (v/v) Tween, 5% (w/v) skimmed
milk powder was added. Serial dilutions were made in 1× PBS, 0.1%
(v/v) Tween (PBST), 1% (w/v) skimmed milk powder, and loaded on an
ELISA plate.
Proteins from the protoplasts, transfected with pRAP-scFv-CK,
pRAP-scFv-SK, and pUCAP35S, were obtained as follows. The cells were
separated from the incubation medium and lysed by adding an equal
volume of 10 mM Tris-HCl, pH 8.0, 1 mM EDTA,
and 1 mM Pefabloc SC (Roche Molecular Biochemicals) and
subsequent vortexing. The lysate was kept at 0 °C for 5 min and at
room temperature for 10 min, and the chloroplasts were removed by
centrifugation at 13,000 × g for 2 min. The
supernatant was diluted with 5 volumes of PBST-1.25% (w/v) skimmed
milk powder and loaded on a 96-well ELISA plate that had been coated
overnight with 2.5 µg/ml cutinase in 50 mM sodium
carbonate, pH 9.6 (100 µl/well). After blocking for 30 min with 200 µl of PBST, 5% skimmed milk powder per well, the plates were washed,
and 100 µl of protein extract per well was added. The plate was
incubated for 2 h. After washing with PBST, each well was
incubated for another 2 h with 100 µl of anti-c-Myc tag antibody
9E10 (1 ng/µl) in PBST, 1% skimmed milk powder. Then, after washing
3 times with PBST, the wells were incubated for 1 h with alkaline
phosphatase-conjugated rat-anti-mouse antibody (Jackson ImmunoResearch)
diluted 1:5000 in PBST, 1% skimmed milk powder. Finally the wells were
washed five times with PBST. 100 µl of substrate (0.75 mg/ml
p-nitrophenylphosphate in 1 M diethanolamine, pH
9.8) was added, and the A405 was
monitored. All incubations were carried out at 37 °C.
 |
RESULTS |
Presence of Disulfide Bonds in the scFvs Located in the ER and
Cytosol--
We previously generated transgenic tobacco plants
expressing functional scFv-CK and scFv-SK antibodies, which were
located in the cytosol and ER, respectively (23, 25). The scFv-SK antibody contains a signal sequence for translocation into the ER
combined with the ER retention signal KDEL (31). The scFv-CK, located
in the cytosol, lacks the ER translocation signal. All scFv antibodies
carry the c-Myc tag sequence for detection purposes.
To compare the in vivo redox state of the disulfide bridges
in the cytosolic scFv-CK and ER-located scFv-SK in both transgenic plants and transfected protoplasts, we isolated protoplasts from transgenic tobacco leaves according to the procedure used for a
transient expression assay. The protoplasts were cooled and immediately
lysed in the presence of the sulfhydryl alkylating agent NEM to
block free thiols and prevent rearrangements of disulfide bonds. The
scFv proteins were analyzed by SDS-PAGE followed by Western blotting
and immuno-detection using the anti-c-Myc antibody, 9E10 (Fig.
2). This showed under non-reducing
conditions for both scFv-CK and scFv-SK, a protein band at 32 kDa, the
estimated molecular mass of the scFv antibodies, and at ~65 kDa (Fig.
2A, lanes 1 and 3). In the presence of
the reducing agent DTT only a protein band at 33 kDa was detected (Fig.
2A, lanes 2 and 4). No protein bands
were detected in protoplasts obtained from the plants transformed with
the empty transformation vector pCPO33T (Fig. 2A, lane
5). Apparently, as reported before (32), the reduction of the two intramolecular disulfide bridges in a scFv antibody results in the
shift in migration from 32 to 33 kDa. The 65-kDa band present in both
the scFv-CK and scFv-SK is only present under oxidizing conditions
(i.e. in the absence of DTT) and, as reported before (23),
shows antigen binding capabilities. This suggests it to be a scFv
dimer, formed through intermolecular disulfide bridge formation by the
cysteine residue present in the linker peptide (Fig. 1). Thus, in
transgenic tobacco, both the cytosolic scFv-CK and ER-located scFv-SK
are present in an oxidized state.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 2.
Determining the redox state of cysteine
residues present in scFv-SK and scFv-CK proteins expressed by stably
transformed plants and in a transient expression assay. Panel
A, Western blot of total protein from stably transformed tobacco
plants expressing scFv-CK and scFv-SK in the absence ( ) or presence
(+) of the reducing agent DTT. The scFv proteins were detected with the
anti-c-Myc antibody 9E10. The positions of the reduced
(red.) and oxidized (ox.) scFv proteins and the
presumed scFv dimer (dimer) are indicated. As a control, a
tobacco plant stably transformed with the empty transformation vector
pCPO33T was used (Control). Panel B, Western blot
of total protein from protoplasts transfected with the vectors
containing the scFv-CK and scFv-SK gene cassettes in the absence ( )
or presence (+) of the reducing agent DTT. The scFv proteins were
detected with the anti-c-Myc antibody 9E10. The positions of the
reduced (red.) and oxidized (ox.) scFv proteins
and the presumed scFv dimer (dimer) are indicated. As a
control, a vector without scFv gene cassette was used
(Control).
|
|
The transfected protoplasts synthesizing scFv-SK also showed the 32- and 65-kDa protein bands under non-reducing conditions and the 33-kDa
band under reducing conditions (Fig 2B, lanes 3 and 4). Both under non-reducing and reducing conditions the
protoplasts transfected with scFv-CK showed only the 33-kDa band (Fig
2B, lanes 1 and 2). Only a weak
background was detected in the transient expression assay when the
empty expression vector pUCAP35S was transfected (Fig. 2B,
lane 5). Therefore, in contrast to scFv-SK, the transiently
expressed scFv-CK lacks the intramolecular and intermolecular disulfide
bridges and, thus, is present in a reduced state. This situation
deviates from the oxidized scFv-CK present in stable transformed plants.
Analysis of the scFv Dimer Formation--
To ascertain that the
65-kDa protein observed in the transgenic plants is formed through
disulfide bridge formation using the cysteine present in the linker, we
modified the linker region in the scFv-SK gene (Fig. 1). The
cysteine-coding triplet (TGT) was changed into a serine-coding triplet
(TCT), creating the scFvser-SK gene. We anticipated that,
if the cysteine residue in the linker peptide was involved in dimer
formation, scFvser-SK expression would not result in the
formation of the disulfide band under non-reducing conditions. We only
modified the scFv-SK gene because we wanted to analyze the 65-kDa band
through a transient expression assay. Because as mentioned before the
scFv-CK synthesized in a transfection assay does not form disulfide
bridges, a transient expression assay with a modified scFv-CK would be
useless to obtain the required information.
The scFv-SK and scFvser-SK genes were both transfected to
tobacco protoplasts, and the synthesized scFv proteins were analyzed by
Western blotting and immuno-detection using the anti-c-Myc antibody,
9E10 (Fig. 3). Under non-reducing conditions scFv-SK expression
resulted in a weak 32-kDa and relatively strong 65-kDa protein band,
and the scFvser-SK expression resulted only in a 32-kDa
protein band (Fig. 3, lanes 1 and 2). Under reducing conditions both scFv-SK and
scFvser-SK expression resulted in 33-kDa protein bands
(Fig. 3, lanes 4 and 5). Under both conditions,
only a weak background was detected in the transient expression assay
with the empty expression vector pUCAP35S (Fig. 3, lanes 3 and 6). The 65-kDa band is only formed under non-reducing
conditions when the cysteine is present in the linker peptide,
indicating that the 65-kDa protein represents a dimerized scFv.

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 3.
Determining the role of the cysteine residue
present in the linker peptide of scFv-SK in dimer formation.
Western blot of total protein from protoplasts transfected with the
vectors containing the scFv-SK and scFvser-SK gene
cassettes in the absence ( DTT) or presence
(+DTT) of the reducing agent dithiothreitol. The scFv
proteins were detected with the anti-c-Myc antibody 9E10. The scFv
monomer and dimer proteins are indicated. As a control a vector without
scFv gene cassette was used (Control).
|
|
The Redox State Influences Binding Properties of scFv-CK--
We
were interested in whether the redox state of the 21C5 anti-cutinase
scFv affected binding to the antigen cutinase. To determine the
affinity by ELISA, we first prepared samples from transgenic tobacco
leaves expressing scFv-CK, scFv-SK, and as a control, untransformed
tobacco (N. tabacum cv. Samsun NN) in the presence of NEM.
To exclude possible negative effects on the affinity by NEM (33), we
also prepared samples in the absence of NEM. The concentration of the
scFv in these crude protein homogenates (Fig.
4A, inset) was
calculated by comparison on Western blots with different concentrations
of purified Ec-scFv, which is the 21C5 anti-cutinase scFv expressed in
the periplasm of E. coli (23).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Antigen binding activity of scFv antibodies
present in crude protein homogenates from leaves of stably transformed
tobacco plants, assayed by ELISA. A, Western blot to
detect scFv-CK and scFv-SK (Fig. 4A, inset) with
the anti-c-Myc antibody 9E10 was used for calculating scFv
concentrations by comparison with different concentrations of purified
scFv from E. coli. Serial dilutions of the scFv-CK ( ) and
scFv-SK ( ) protein homogenates and purified scFv from E. coli (Ec-scFv) (×, NEM; , +NEM) were incubated in wells
coated with 250 ng of cutinase. Individual points represent mean
values of duplicate trials with S.D. (error bars). Protein
samples were prepared in the presence (panel A; +NEM) and in
the absence (Panel B; NEM) of the sulfhydryl
alkylating agent N-ethylmaleimide.
|
|
Serial dilutions in duplicate of the scFv-SK and scFv-CK and
untransformed tobacco samples were loaded on an ELISA plate coated with
cutinase. As a reference duplicate serial dilutions of NEM-treated purified Ec-scFv were included in the assay. Fig. 4A shows
the comparison of the antigen binding activity of scFv-CK and scFv-SK, both in the crude transgenic plant extracts, and purified Ec-scFv. Apparently, the binding properties are very similar. The plant proteins
in the crude homogenates did not affect the A405
values, as determined for the control samples, prepared from
untransformed plants (not shown). Treatment with NEM does not affect
the antigen binding properties of the anti-cutinase scFv since the
samples prepared in the absence of NEM also show no significant
difference in antigen binding activity in the same experiment
(Fig. 4B).
Next NEM-treated samples were prepared from the protoplasts transfected
with the scFv-CK and scFv-SK expression vectors and the empty vector
pUCAP35S as described before. As shown, the migration rate and the
presence of the 65-kDa protein band indicates the redox state of the
scFv antibody. Western analysis of the protoplasts showed 32- and
65-kDa bands for scFv-SK, indicating the oxidized nature, and a
33-kDa protein band for scFv-CK, indicating the reduced nature
(Fig. 5A). The concentration of the scFv
in these crude protein homogenates was calculated at 8 ng/µl for both
scFv-SK and scFv-CK by comparison with different concentrations of
Ec-scFv on SDS-PAGE followed by Western blotting and immuno-detection using the anti-c-Myc antibody, 9E10. An ELISA binding assay was performed in triplicate using 150 ng of scFv-CK and scFv-SK. To calculate the binding, duplicate serial dilutions of NEM-treated Ec-scFv were included in the assay. Fig. 5 shows the comparison of the
antigen binding activity of scFv-CK and scFv-SK, both obtained from
transfected protoplasts. Because the antigen binding activity of the
Ec-scFv was similar to oxidized scFv-SK and scFv-CK (see Fig. 4), we
calculated from the Ec-scFv reference that the
A405 value correlated to an amount of 130 ± 5.1 ng of scFv-SK bound/well after correcting for the background
caused by aspecific binding of plant proteins from the crude homogenate
(Fig. 5B). Of the scFv-CK, only 8.0 ± 0.8 ng/well was
bound. It can therefore be concluded that in comparison to the oxidized
scFv-SK, less than 10% of the scFv-CK input remained bound to
cutinase. The alkylation of the cysteines by NEM did not cause the
reduction in binding strength of the reduced scFv-CK as was determined
by sample preparation in the absence of NEM (not shown). This indicates
that the reduced scFv-CK antibody has a considerable reduced binding
strength when compared with the oxidized scFv-SK and scFv-CK.
Apparently, the absence of intramolecular disulfide bridges has a
considerable negative effect on the binding strength of the
anti-cutinase scFv.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Binding of transiently expressed scFv-SK and
scFV-CK antibodies to cutinase. Panel A, Western blot of
total protein homogenates prepared in the presence of NEM from
protoplasts, transfected with the vectors containing the scFv-CK and
scFv-SK gene cassettes in the absence of the reducing agent DTT. The
blot was used for calculating scFv concentrations by comparison with
different concentrations of purified scFv from E. coli. The
scFv proteins were detected with the anti-c-Myc antibody (9E10).
Panel B, protein homogenates containing 150 ng of the
scFv-CK and scFv-SK (black bars), and serial dilutions of
scFv purified from E. coli were incubated in wells coated
with 250 ng of cutinase in triplicate. The serial dilutions were used
to calculate the amount of bound scFv-SK and scFV-CK to cutinase
(spotted bars). The dotted bars represent the
mean values of bound scFv-SK and scFV-CK with S.D (error
bars), corrected for the protoplast homogenate transfected with
the empty vector pUCAP35S. The antibodies were detected with the
anti-c-Myc antibody (9E10).
|
|
 |
DISCUSSION |
The capability of a scFv antibody to form disulfide bridges in the
cytosol is remarkable. Protein disulfide isomerase, a catalyst in the
oxidative folding, is not present in the cytosol, and the estimated
GSH/GSSG ratios of 30-100 do not favor disulfide bridge formation. It
was calculated that RNase A, which efficiently refolds at a GSH/GSSG
ratio of 2 in the presence of protein disulfide isomerase, would not be
able to refold at the cytosolic GSH/GSSG ratios both in the presence
and absence of protein disulfide isomerase (3). This demonstrates that
disulfide bridge formation in proteins is very much dependent on the
GSH/GSSG ratio of the subcellular compartment. Cell-free translation
assays in the presence of protein disulfide isomerase and added
bacterial chaperones showed that a scFv antibody fragment folds better
at mildly reducing conditions, i.e. a GSH/GSSG ratio of 10 at 1.1 mM total glutathione, than at oxidizing conditions
(34). Bacterial chaperones did not promote the proper disulfide bridge
formation, and it was suggested that protein disulfide isomerase merely
served in disulfide rearrangements rather than in disulfide formation.
Our results indicate that in vivo disulfide bridge formation
in scFvs is possible at GSH/GSSG ratios found in the plant cytosol.
Consequently, if these ratios correspond to the ratios found in the
cytosol of cultured murine hybridoma CRL-1606 cells (3), the scFv
antibody is capable of forming disulfide bridges at GSH/GSSG ratios of
30 or higher. The GSH/GSSG ratio and the GSH concentration in the
cytosol of tobacco leaf cells are unknown and will be difficult to
determine due to the presence of the large central vacuole. However, it is possible that this ratio deviates or that the GSH concentration is
relatively low. The total GSH/GSSG ratio of the phloem exudates of
Cucurbita (35) and Ricinus (36) was calculated at
13 and 3, respectively. Because phloem exudates represent the cytosol of a plant cell, this total GSH/GSSG ratio represents the cytosolic ratio. In addition, in pumpkin leaves, low concentrations of total GSH
were measured. The concentration of GSH also has great influence on
disulfide bridge formation in proteins (2).
The presence of certain eukaryotic cytosolic chaperones (37) may
facilitate the efficient folding of the VL and
VH domains and prevent aggregation through erroneous
disulfide bridge formation. Once folded into the native structure, the
disulfide bridges are inaccessible for reduced glutathione due to a
tight surrounding structure (33, 38). However, proper folding does not
always guarantee disulfide bridge formation, as illustrated by the
absence of disulfide bridges in two other functional cytosolic scFv
antibody fragments in stably transformed tobacco and petunia plants
(39, 40). That folding in our scFv antibody is accurate is emphasized by the 202' linker derivative with the cysteine residue. Even this
extra cysteine does not result in an aberrant disulfide bridge formation and results in a partial but rather organized dimerization.
As demonstrated by the transfection experiments, the plant cytosol can
under circumstances also be reducing enough to prevent disulfide bridge
formation. This confirms that the redox state of the plant cytosol is
not fixed and that redox modulation may play an important role in the
physiology of the plant cell as suggested before. Why the cytosol of
protoplasts is more reducing remains a question. Incubation of the
protoplasts after transfection occurs in the dark, and therefore, the
cytosol is presumed to be more oxidized when compared with illuminated
protoplasts (22). This should favor disulfide bridge formation, which
would contradict our observations. It may well be that the protoplasts,
which are kept under non-natural conditions, protect themselves against an oxidative stress situation. The levels of GSH in foliar tissues have
been shown to increase under various oxidative stress conditions (41).
Furthermore, extracellular added GSH was also shown to act as an
activator of the transcription of genes encoding the cell wall
hydroxyproline-rich glycoproteins and phenylpropanoid biosynthetic enzymes in cultured suspension cells or protoplasts of
bean, soybean, and alfalfa (42, 43).
Our results also raise the question of whether such oxidative stress
reactions also apply for other types of eukaryotic cell cultures. In
other words, is the GSH/GSSG ratio in the cytosol of cultured animal
cells higher than the ratio in the cytosol of the tissue from which the
cells are derived? If in all cases the scFv functionality is indeed a
marker for the presence of disulfide bridges, the reported successes
with respect to cytosolic expression of scFvs for introducing
resistance against pathogens, like viruses (44-48), or modifying
phenotypic traits (49-53) would imply the presence of disulfide
bridges. As in stably transformed plant cells, this may not always be
the case, since Biocca et al. (54) report that a functional
cytosolic anti-p21ras scFv, expressed in
Xenopus oocytes, lacked disulfide bridges. To date, nothing
is known about disulfide bridge formation in scFv antibodies in the
cytosol of other eukaryotic cell culture types.
As our results show, scFv antibodies can also form intermolecular
disulfide bridges in the plant cytosol. Maciejewski et al. (55) report the functional expression of an anti-human immunodeficiency virus1 reverse transcriptase Fab fragment in the cytosol of lymphoid cell lines, leading to a blockade of virus replication. Although it was
demonstrated that uninfected cells expressed unassembled Fab fragments,
i.e. without intermolecular disulfide bridges, it may have
been that assembly may have occurred during infection since HIV
infection strongly decreases the intracellular reduced glutathione
concentration (21).
Our results also demonstrate that scFv antibodies without disulfide
bridges can be found as a soluble and poorly functional protein in the
plant cytosol. However, its stability does not seem to be affected.
This is in contrast to heterologous scFv expression in E. coli (38), where the formation of the intramolecular disulfide
bonds in both the variable heavy and light domains are considered
crucial for stability. Apparently, next to the redox potential, the
environment of the plant cytosol differs in other aspects from the
E. coli cytosol. It was reported by Freund et al.
(56) that in vitro a scFv antibody folds through an early and fast folding intermediate followed by a slow folding process into
the final structure. As mentioned, certain chaperones not present in
the cytosol of E. coli may play an important role in stabilizing and maintaining a folding intermediate of the scFv antibody. It may therefore be that the disulfide bridge formation required for the final folding steps to acquire the fully folded structure is prevented due to the reducing environment.
This report illustrates that it is impossible to predict a
priori to what extent a given protein sulfhydryl will
remain reduced in the cytosol. This was also suggested by Piñeiro
et al. (57). Bacterial genes coding for the cytosolic
enzymes neomycin phosphotransferase II and
-glucuronidase were
transiently expressed in the cytosol of tobacco protoplasts. Because
the typical GSH/GSSG ratio in E. coli ranges from 50 to 300 they reasoned that the GSH/GSSG ratio of 30-100 in the plant cytosol
was not sufficiently reducing to prevent disulfide bridge formation in
these enzymes, resulting in a reduced stability. Thus, in cases in
which disulfide bridges determine functionality and/or stability of a
protein, the result of heterologous expression of the coding gene in
the cytosol may be difficult to foresee.
Expression in plant cytosol of functional scFvs has proven to be
feasible and, therefore, offers good perspective with respect to their
use in intracellular immunization and immuno modulation approaches.
However, the choice of the expression system should be made carefully
and guarantee a redox state of the heterologously expressed protein,
which represents the situation in the natural tissue. Transient
expression assays by transfecting cell suspensions may, therefore, be
only representative for protein expression levels rather than
functionality in the cytosol.
 |
FOOTNOTES |
*
This research was supported by grants from the Netherlands
Technology Foundation (STW) coordinated through the Foundation for Life Sciences (SLW). Additional support was obtained from European
Community grants BIO2-CT92-0239 and FAIR1-CT95-0905.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Laboratory of
Phytopathology, Dept. of Plant Sciences, Wageningen University, P. O.
Box 8025, 6700 EE Wageningen, The Netherlands. Tel.: 31-317-485813; Fax: 31-317-483412; E-mail: sander.schouten@fyto.dpw.wau.nl.
Published, JBC Papers in Press, March 26, 2002, DOI 10.1074/jbc.M201245200
 |
ABBREVIATIONS |
The abbreviations used are:
ER, endoplasmic
reticulum;
scFv, single-chain Fv;
NEM, N-ethylmaleimide;
DTT, dithiothreitol;
ELISA, enzyme-linked immunosorbent assay;
PBS, phosphate-buffered saline;
PBST, PBS with 0.1% (v/v) Tween.
 |
REFERENCES |
| 1.
|
Ziegler, D. M.
(1985)
Annu. Rev. Biochem.
54,
305-329[Medline]
[Order article via Infotrieve]
|
| 2.
|
Gilbert, H. F.
(1990)
Adv. Enzymol.
63,
69-172[Medline]
[Order article via Infotrieve]
|
| 3.
|
Hwang, C.,
Sinskey, A. J.,
and Lodish, H. F.
(1992)
Science
257,
1496-1502[Abstract/Free Full Text]
|
| 4.
|
Gething, M.-J.,
and Sambrook, J.
(1992)
Nature
355,
33-44[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Alberini, C. M.,
Bet, P.,
Milstein, C.,
and Sitia, R.
(1990)
Nature
347,
485-487[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Braakman, I.,
Helenius, J.,
and Helenius, A.
(1992)
Nature
356,
260-262[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Tatu, U.,
Braakman, I.,
and Helenius, A.
(1993)
EMBO J.
12,
2151-2157[Medline]
[Order article via Infotrieve]
|
| 8.
|
Chanat, E.,
Weiss, U.,
Huttner, W. B.,
and Tooze, S. A.
(1993)
EMBO J.
12,
2159-2168[Medline]
[Order article via Infotrieve]
|
| 9.
|
Jämsä, E.,
Simonen, M.,
and Makarow, M.
(1994)
Yeast
10,
355-370[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
de Vries, A. A. F.,
Raamsman, M. J. B.,
van Dijk, H. A.,
Horzinek, M. C.,
and Rottier, P. J. M.
(1995)
J. Virol.
69,
3441-3448[Abstract]
|
| 11.
|
Thornton, J. M.
(1981)
J. Mol. Biol.
151,
261-287[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Sengupta, S.,
Chen, H.,
Togawa, T.,
DiBello, P. M.,
Majors, A. K.,
Büdy, B.,
Ketterer, M. E.,
and Jacobsen, D. W.
(2001)
J. Biol. Chem.
276,
30111-30117[Abstract/Free Full Text]
|
| 13.
|
Sengupta, S.,
Wehbe, C.,
Majors, A. K.,
Ketterer, M. E.,
DiBello, P. M.,
and Jacobsen, D. W.
(2001)
J. Biol. Chem.
276,
46896-46904[Abstract/Free Full Text]
|
| 14.
|
Hérouart, D.,
van Montagu, M.,
and Inzé, D.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
3108-3112[Abstract/Free Full Text]
|
| 15.
|
Parks, D.,
Bolinger, R.,
and Mann, K.
(1997)
Nucleic Acids Res.
25,
1289-1295[Abstract/Free Full Text]
|
| 16.
|
Abate, C.,
Patel, L.,
Rauscher, F. J., III,
and Curran, T.
(1990)
Science
249,
1157-1161[Abstract/Free Full Text]
|
| 17.
|
Staal, F. J. T.,
Roederer, M.,
Herzenberg, L. A.,
and Herzenberg, L. A.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
9943-9947[Abstract/Free Full Text]
|
| 18.
|
Anderson, L. E., Li, D.,
Prakash, N.,
and Stevens, F. J.
(1995)
Planta
196,
118-124[Medline]
[Order article via Infotrieve]
|
| 19.
|
Rennenberg, H.,
and Filner, P.
(1982)
Plant Physiol.
69,
766-770[Abstract/Free Full Text]
|
| 20.
|
Lodish, H. F.,
and Kong, N.
(1993)
J. Biol. Chem.
268,
20598-20605[Abstract/Free Full Text]
|
| 21.
|
Garaci, E.,
Palamara, A. T.,
Ciriolo, M. R.,
D'Agostini, C., Ab,
del-Latif, M. S.,
Aquaro, S.,
Lafivia, E.,
and Rotillio, G.
(1997)
J. Leukocyte Biol.
62,
54-59[Abstract]
|
| 22.
|
Cséke, C.,
and Buchanan, B. B.
(1986)
Biochim. Biophys. Acta
853,
43-63
|
| 23.
|
Schouten, A.,
Roosien, J.,
van Engelen, F. A.,
de Jong, G. A. M.,
Borst-Vrenssen, A. W. M.,
Zilverentant, J. F.,
Bosch, D.,
Stiekema, W. J.,
Gommers, F. J.,
Schots, A.,
and Bakker, J.
(1996)
Plant Mol. Biol.
30,
781-793[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 25.
|
Schouten, A.,
Roosien, J.,
de Boer, J. M.,
Wilmink, A.,
Rosso, M.-N.,
Bosch, D.,
Stiekema, W. J.,
Gommers, F. J.,
Bakker, J.,
and Schots, A.
(1997)
FEBS Lett.
415,
235-241[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
van Engelen, F. A.,
Molthoff, J. W.,
Conner, A. J.,
Nap, J. P.,
Pereira, A.,
and Stiekema, W. J.
(1995)
Transgenic Res.
4,
288-290[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Sanger, F.,
Nicklen, S.,
and Coulson, A. R.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
5463-5467[Abstract/Free Full Text]
|
| 28.
|
Denecke, J.,
Gosselé, V.,
Botterman, J.,
and Cornelissen, M.
(1989)
Methods Mol. Cell Biol.
1,
19-27
|
| 29.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Munro, S.,
and Pelham, H. R. B.
(1986)
Cell
46,
291-300[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Pelham, H. R. B.
(1989)
EMBO J.
8,
3171-3176[Medline]
[Order article via Infotrieve]
|
| 32.
|
Biocca, S.,
and Cattaneo, A.
(1995)
Trends Cell Biol.
5,
248-252[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Goto, Y.,
and Hamaguchi, K.
(1979)
J. Biochem.
86,
1433-1441[Abstract/Free Full Text]
|
| 34.
|
Ryabova, L. A.,
Desplancq, D.,
Spirin, A. S.,
and Plückthun, A.
(1997)
Nat. Biotechnol.
15,
79-84[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Alosi, M. C.,
Melroy, D. L.,
and Park, R. B.
(1988)
Plant Physiol.
86,
1089-1094[Abstract/Free Full Text]
|
| 36.
|
Szederkényi, J.,
Komor, E.,
and Schobert, C.
(1997)
Planta
202,
349-356[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Ruddon, R. W.,
and Beddows, E.
(1997)
J. Biol. Chem.
272,
3125-3128[Free Full Text]
|
| 38.
|
Glockshuber, R.,
Schmidt, T.,
and Plückthun, A.
(1992)
Biochemistry
31,
1270-1279[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
De Jaeger, G.,
Buys, E.,
Eeckhout, D., De,
Wilde, C.,
Jacobs, A.,
Kapila, J.,
Angenon, G.,
Van Montagu, M.,
Gerats, T.,
and Depicker, A.
(1999)
Eur. J. Biochem.
259,
426-434[Medline]
[Order article via Infotrieve]
|
| 40.
|
Tavladoraki, P.,
Girotti, A.,
Donini, M.,
Arias, F. J.,
Mancini, C.,
Morea, V.,
Chiaraluce, R.,
Consalvi, V.,
and Benvenuto, E.
(1999)
Eur. J. Biochem.
262,
617-624[Medline]
[Order article via Infotrieve]
|
| 41.
|
Alscher, R. G.
(1989)
Physiol. Plant.
77,
457-464
|
| 42.
|
Wingate, V. P. M.,
Lawton, M. A.,
and Lamb, C. J.
(1988)
Plant Physiol.
87,
206-210[Abstract/Free Full Text]
|
| 43.
|
Choudary, A. D.,
Lamb, C. J.,
and Dixon, R. A.
(1990)
Plant Physiol.
94,
1802-1807[Abstract/Free Full Text]
|
| 44.
|
Tavladoraki, P.,
Benvenuto, E.,
Trinca, S.,
Demartinis, D.,
Cattaneo, A.,
and Galeffi, P.
(1993)
Nature
366,
469-472[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Duan, L. X.,
Bagasra, O.,
Laughlin, M. A.,
Oakes, J. W.,
and Pomerantz, R. J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
5075-5079[Abstract/Free Full Text]
|
| 46.
|
Jiang, W. R.,
Venugopal, K.,
and Gould, E. A.
(1995)
J. Virol.
69,
1044-1049[Abstract]
|
| 47.
|
Mhashilkar, A. M.,
Bagley, J.,
Chen, S. Y.,
Szilvay, A. M.,
Helland, D. G.,
and Marasco, W. A.
(1995)
EMBO J.
14,
1542-1551[Medline]
[Order article via Infotrieve]
|
| 48.
|
Shaheen, F.,
Duan, L. X.,
Zhu, M. H.,
Bagasra, O.,
and Pomerantz, R. J.
(1996)
J. Virol.
70,
3392-3400[Abstract]
|
| 49.
|
Owen, M.,
Gandecha, A.,
Cockburn, B.,
and Whitelam, G.
(1992)
Bio/Technology
10,
790-794[Medline]
[Order article via Infotrieve]
|
| 50.
|
Biocca, S.,
Pierandreiamaldi, P.,
and Cattaneo, A.
(1993)
Biochem. Biophys. Res. Commun.
197,
422-427[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Biocca, S.,
Pierandreiamaldi, P.,
Campioni, N.,
and Cattaneo, A.
(1994)
Bio/Technology
12,
396-399[Medline]
[Order article via Infotrieve]
|
| 52.
|
Werge, T. M.,
Baldari, C. T.,
and Telford, J. L.
(1994)
FEBS Lett.
351,
393-396[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Fecker, L. F.,
Koenig, R.,
and Obermeier, C.
(1997)
Arch. Virol.
142,
1857-1863[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Biocca, S.,
Ruberti, F.,
Tafani, R.,
Pierandreiamaldi, P.,
and Cattaneo, A.
(1995)
Bio/Technology
13,
1110-1115[Medline]
[Order article via Infotrieve]
|
| 55.
|
Maciejewski, J. P.,
Weichold, F.,
Young, N. S.,
Cara, A.,
Zella, D.,
Reitz, M. S., Jr.,
and Gallo, R. C.
(1995)
Nature Med.
1,
667-673[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Freund, C.,
Honegger, A.,
Hunziker, P.,
Holak, T. A.,
and Plückthun, A.
(1996)
Biochemistry
35,
8457-8464[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Piñeiro, M.,
García-Olmedo, F.,
and Diaz, I.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
3867-3871[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Prins, D. Lohuis, A. Schots, and R. Goldbach
Phage display-selected single-chain antibodies confer high levels of resistance against Tomato spotted wilt virus
J. Gen. Virol.,
July 1, 2005;
86(7):
2107 - 2113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Artsaenko, K. Tessmann, M. Sack, D. Haussinger, and T. Heintges
Abrogation of hepatitis C virus NS3 helicase enzymatic activity by recombinant human antibodies
J. Gen. Virol.,
September 1, 2003;
84(9):
2323 - 2332.
[Abstract]
[Full Text]
[PDF]
|
 |
|